Intelligent Bio Solutions Inc.

INBS Healthcare Medical Devices

Intelligent Bio Solutions Inc.’s revenue for fiscal 2026 (year ended June 2026) was $4.2 million, up 38.1% from fiscal 2025. In the quarter to June 2026, revenue grew 51.1%, EPS grew 78.1% and free cash flow fell 31.6%, each against the same quarter a year earlier.

1.50 0.06 +4.17%
Market cap
$4.8M
P/E
0.0×
Fwd P/E
5.4×
Dividend yield
—
F-score
5/9
Altman Z
−11.40
Beneish M
−2.45
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

(231.78%) (149.66%) (169.60%) (306.76%)
Piotroski F-Score
3 4 4 5
ROA
(99.85%) (85.77%) (95.01%) (123.13%)
ROIC
(387.48%) (69.74%) (387.05%) (606.86%)
Return on Tangible Assets
3,551.01% (153.26%) (213.05%) (504.77%)
Average Days of Receivables
182.05 1,074.54 137.10 143.34
Free Cash Flow per Share
(11.86) (10.21) (7.06) (8.30)
Free Cash Flow
(10.14) (9.71) (11.26) (12.22)
Other line items

Show all line items

Columns are period end dates